Skip to content

Warenkorb

Der Warenkorb ist leer.

Gesamt (exkl. MwSt.) £0,00
Warenkorb überprüfen & bezahlen
Antikörper

Anti-Cytokeratin 8 (KRT8) Monoclonal Antibody(Clone: KRT8/2115)

Produktgrößen
20 µg
£397,00
36-2659-20UG
100 µg
£716,00
36-2659-100UG
Über dieses Produkt
SKU:
36-2659
Zusätzliche Namen:
CARD2; CK8; CYK8; CYKER; Cytokeratin Endo A; DreK8; EndoA; K2C8; K8; Keratin 8; Krt 2.8; KRT8; Type-II Keratin Kb8
translate.label.attr.clone:
KRT8/2115
Klonalität:
Monoclonal
Weitere Details:
Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia; including many ductal and glandular epithelia such as colon; stomach; small intestine; trachea; and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma; chordoma; and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8; CK18 and CK19). Reportedly; anti-CK8 is useful for the differentiation of lobular ('ring-like; perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast.
Host:
Mouse
Immunogen:
Recombinant full-length human KRT8 protein
Isotyp:
Mouse IgG1; kappa
Reaktivitäten:
Human
Versandbedingungen:
Blue Ice
Lagerbedingungen:
Antibody with azide - store at 2 to 8[o]C. Antibody without azide - store at -20 to -80[o]C. Antibody is stable for 24 months. Non-hazardous.
Hersteller:
Abeomics
Typ:
Antibodies:Monoclonal Antibody
  • Datenblatt des Herstellers:1.jpg